Filing Flows

Filing Flows › Bionano Genomics (BNGO) › How it makes money

How Bionano Genomics (BNGO) makes money

Bionano Genomics (BNGO) made $8.2M of revenue in the second quarter 2026 (Q2 2026), +21% from a year earlier. Product brought in $7.7M (94%); Product and Service Other brought in $478K (6%).

Drawing the Sankey…

Bionano Genomics revenue by segment, Q2 2026Bionano Genomics revenue by segment, Q2 2026Product$7.7MProduct and Service Other$478K
Bionano Genomics: revenue by line, Q4 2025 to Q2 2026Bionano Genomics: revenue by line, Q4 2025 to Q2 2026ProductProduct and Service O…Product: $7.7M latest$7.7MProduct and Service Other: $478K latestQ4 2025Q1 2026Q2 2026
The mix barely moved between Q4 2025 and Q2 2026.
Bionano Genomics revenue by quarterBionano Genomics revenue by quarter$8.2MQ4 2024$6.5MQ1 2025$6.7MQ2 2025$7.4MQ3 2025$8.0MQ4 2025$6.7MQ1 2026$8.2MQ2 2026
Bionano Genomics: where each dollar of revenue goesBionano Genomics: where each dollar of revenue goesIncome tax0¢

Revenue by segment, Q2 2026

SegmentRevenueShareQ/QY/Y
Product$7.7M94.2%+26%+22%
  ↳ Consumable Revenue$4.3M52.4%+10%+31%
  ↳ Instrument Revenue$2.0M24.9%+112%+46%
  ↳ Software Revenue$1.4M16.8%+11%-16%
Product and Service Other$478K5.8%-19%+13%

Where each dollar of revenue goes

LineQ2 2026% of revenue
Revenue$8.2M100.0%
Income tax$7K0.1%

Revenue, quarter by quarter

QuarterRevenueY/Y
Q2 2026$8.2M+21%
Q1 2026$6.7M+4%
Q4 2025$8.0M-3%
Q3 2025$7.4M+21%
Q2 2025$6.7M-13%
Q1 2025$6.5M-26%
Q4 2024$8.2M-24%

From Bionano Genomics' 10-Q filed Aug 10, 2026 (on EDGAR).

Questions

How does Bionano Genomics make money?

Bionano Genomics (BNGO) made $8.2M of revenue in the second quarter 2026 (Q2 2026), +21% from a year earlier. Product brought in $7.7M (94%); Product and Service Other brought in $478K (6%).

What is Bionano Genomics' biggest business?

Product: $7.7M in the second quarter 2026, 94% of revenue, +22% from a year earlier.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.